Does FUTIBATINIB Cause Disease progression? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Disease progression have been filed in association with FUTIBATINIB (LYTGOBI). This represents 12.4% of all adverse event reports for FUTIBATINIB.
20
Reports of Disease progression with FUTIBATINIB
12.4%
of all FUTIBATINIB reports
5
Deaths
6
Hospitalizations
How Dangerous Is Disease progression From FUTIBATINIB?
Of the 20 reports, 5 (25.0%) resulted in death, 6 (30.0%) required hospitalization.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FUTIBATINIB. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does FUTIBATINIB Cause?
Death (30)
Diarrhoea (29)
Hyperphosphataemia (22)
Nausea (21)
Dry mouth (18)
Fatigue (18)
Off label use (16)
Vomiting (15)
Dry eye (13)
Constipation (12)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which FUTIBATINIB Alternatives Have Lower Disease progression Risk?
FUTIBATINIB vs GABAPENTIN
FUTIBATINIB vs GABAPENTIN ENACARBIL
FUTIBATINIB vs GADAVIST
FUTIBATINIB vs GADOBENATE DIMEGLUMINE
FUTIBATINIB vs GADOBUTROL